Top 5 Stocks to Buy Now
→ Quick favor to ask you (From Profits Run) (Ad)tc pixel Free CINGW Stock Alerts

Cingulate (CINGW) Competitors

$0.02 0.00 (-0.42%)
As of 06/23/2026 11:14 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

CINGW vs. AIMDW, ALVOW, ACABW, BFRIW, and CELUW

Should you buy Cingulate stock or one of its competitors? MarketBeat compares Cingulate with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cingulate include Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

How does Cingulate compare to Ainos?

Cingulate (NASDAQ:CINGW) and Ainos (NASDAQ:AIMDW) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, media sentiment, analyst recommendations, dividends, earnings and institutional ownership.

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Ainos'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Ainos Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Ainos$18.11KN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Ainos N/A N/A N/A

Summary

Ainos beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$559.42MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Alvotech Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Alvotech beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Atlantic Coastal Acquisition Corp. II?

Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) and Cingulate (NASDAQ:CINGW) are both pharmaceutical products companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Atlantic Coastal Acquisition Corp. II's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Atlantic Coastal Acquisition Corp. II Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
Atlantic Coastal Acquisition Corp. IIN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Atlantic Coastal Acquisition Corp. II and Cingulate tied by winning 0 of the 0 factors compared between the two stocks.

How does Cingulate compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Cingulate (NASDAQ:CINGW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company Overall Sentiment
Biofrontera Neutral
Cingulate Neutral

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Biofrontera beats Cingulate on 1 of the 1 factors compared between the two stocks.

How does Cingulate compare to Celularity?

Cingulate (NASDAQ:CINGW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, Cingulate's average media sentiment score of 0.00 equaled Celularity'saverage media sentiment score.

Company Overall Sentiment
Cingulate Neutral
Celularity Neutral

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
Celularity N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

Summary

Celularity beats Cingulate on 1 of the 1 factors compared between the two stocks.

Get Cingulate News Delivered to You Automatically

Sign up to receive the latest news and ratings for CINGW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

Export
MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$465.79M$6.44B$12.39B
Dividend YieldN/A3.86%2.69%5.83%
P/E RatioN/A3.1824.9023.99
Price / SalesN/A6,492.01527.78108.89
Price / CashN/A13.1344.8254.51
Price / BookN/A91.1710.796.50
Net IncomeN/A-$96.07M$3.56B$336.88M
7 Day PerformanceN/A1.08%1.00%-0.14%
1 Month PerformanceN/A0.72%0.42%0.77%
1 Year PerformanceN/A64.46%29.70%28.49%

Cingulate Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.02
-0.4%		N/A-68.7%$0.00N/AN/A20
AIMDW
Ainos
N/A$0.15
-0.4%		N/A-21.8%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.33
-11.2%		N/A-85.5%$0.00$559.42MN/A4
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
-26.5%		N/A-90.5%$0.00N/AN/A15
BFRIW
Biofrontera
N/A$0.04
+53.2%		N/A-65.6%$0.00$43.20MN/A70

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:CINGW) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...
Stansberry Research | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Top Banks Warn: A Strange Day is Coming to America
Goldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...
TradeSmith | Sponsoredtc pixel
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets | Sponsoredtc pixel
Read this before you touch SPCX
SPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...
Altimetry | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Karp just filed Form 144
On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...
Porter & Company | Sponsoredtc pixel